| Primary |
| High Grade B-cell Lymphoma Burkitt-like Lymphoma |
16.0% |
| Meningitis Cryptococcal |
9.7% |
| Chronic Lymphocytic Leukaemia Refractory |
6.9% |
| Hepatic Candidiasis |
6.9% |
| Acute Myeloid Leukaemia |
5.1% |
| Fungal Infection |
5.1% |
| Chronic Myeloid Leukaemia |
4.6% |
| Diffuse Large B-cell Lymphoma |
4.6% |
| Immunosuppression |
4.6% |
| Pneumonia |
4.6% |
| Pyrexia |
4.0% |
| Cerebral Toxoplasmosis |
3.4% |
| Cytomegalovirus Infection |
3.4% |
| Febrile Neutropenia |
3.4% |
| Paronychia |
3.4% |
| Renal Failure |
3.4% |
| Systemic Mycosis |
3.4% |
| Oesophageal Candidiasis |
2.9% |
| Bronchopulmonary Aspergillosis |
2.3% |
| Candidiasis |
2.3% |
|
| Tachycardia |
12.3% |
| Muscular Weakness |
8.8% |
| Neutropenia |
8.8% |
| Pyrexia |
8.8% |
| Overdose |
7.0% |
| Pancytopenia |
7.0% |
| Renal Impairment |
7.0% |
| Anaphylactic Shock |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Drug Administration Error |
3.5% |
| Fungal Endocarditis |
3.5% |
| Hypothermia |
3.5% |
| Renal Failure |
3.5% |
| Thrombocytopenia |
3.5% |
| Weight Increased |
3.5% |
| Anaphylactic Reaction |
1.8% |
| Angioedema |
1.8% |
| Cardiac Arrest |
1.8% |
| Cholecystitis |
1.8% |
| Congenital Central Nervous System Anomaly |
1.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.7% |
| Product Used For Unknown Indication |
21.4% |
| Acute Myeloid Leukaemia |
5.6% |
| Bronchopulmonary Aspergillosis |
4.8% |
| Prophylaxis |
4.1% |
| Pyrexia |
4.1% |
| Acute Lymphocytic Leukaemia |
3.7% |
| Lung Transplant |
3.6% |
| Pain |
3.6% |
| Systemic Mycosis |
3.2% |
| Infection |
3.2% |
| Renal Transplant |
2.9% |
| Injury Corneal |
2.8% |
| Cranial Nerve Disorder |
2.7% |
| Gastritis Prophylaxis |
2.4% |
| Fungal Infection |
2.2% |
| High Grade B-cell Lymphoma Burkitt-like Lymphoma |
2.2% |
| Diabetes Mellitus |
1.7% |
| Gastrointestinal Disorder |
1.6% |
| Candidiasis |
1.5% |
|
| Vomiting |
9.6% |
| Thrombocytopenia |
8.7% |
| Cytolytic Hepatitis |
7.0% |
| Hepatic Function Abnormal |
6.1% |
| Renal Failure Acute |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Renal Impairment |
5.2% |
| Tachycardia |
5.2% |
| Toxic Skin Eruption |
5.2% |
| Liver Disorder |
4.3% |
| Pyrexia |
4.3% |
| Sepsis |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Anaphylactic Shock |
3.5% |
| Death |
3.5% |
| Henoch-schonlein Purpura |
3.5% |
| Memory Impairment |
3.5% |
| Tongue Necrosis |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Hemiplegia |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Prophylaxis |
20.6% |
| Drug Use For Unknown Indication |
13.4% |
| Multiple Myeloma |
7.1% |
| Hiv Infection |
4.8% |
| Infection Prophylaxis |
4.1% |
| Hypertension |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Psoriatic Arthropathy |
2.7% |
| Acute Myeloid Leukaemia |
2.6% |
| Insomnia |
2.1% |
| Pneumonia |
2.1% |
| Antifungal Prophylaxis |
2.0% |
| Renal Transplant |
2.0% |
| Constipation |
2.0% |
| Immunosuppression |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Stem Cell Transplant |
1.4% |
| Refractory Cancer |
1.4% |
| Juvenile Arthritis |
1.2% |
|
| White Blood Cell Count Decreased |
17.1% |
| Vomiting |
8.8% |
| Thrombocytopenia |
6.9% |
| Interstitial Lung Disease |
6.1% |
| Pyrexia |
5.1% |
| Shock |
5.1% |
| Respiratory Failure |
4.8% |
| Renal Failure Acute |
4.5% |
| Sepsis |
4.5% |
| Rash |
4.0% |
| Septic Shock |
4.0% |
| Pancytopenia |
3.7% |
| Staphylococcal Sepsis |
3.7% |
| Histiocytosis Haematophagic |
3.5% |
| Renal Impairment |
3.5% |
| Pneumonia |
3.2% |
| Anaemia |
2.9% |
| Liver Disorder |
2.9% |
| Neutropenia |
2.9% |
| Streptococcal Infection |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Fungal Infection |
16.7% |
| Urinary Incontinence |
8.3% |
|
| Femoral Neck Fracture |
50.0% |
| Prothrombin Level Decreased |
50.0% |
|
